Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A pharmacogenetic study of risperidone on chemokine (C-C motif) ligand 2 (CCL2) in Chinese Han schizophrenia patients.

Progress in neuro-psychopharmacology & biological psychiatry - 3 Jun 2014

Xiong Yuyu, Wei Zhiyun, Huo Ran, Wu Xi, Shen Lu, Li Yang, Gong Xueli, Wu Zhenqiang, Feng Guoyin, Li Wenqiang, He Lin, Xing Qinghe, Qin Shengying

Abstract excerpt

Previous observations of the pathophysiological distribution and pharmacological profile of the chemokine (C-C motif) ligand 2 (CCL2) have indicated its potential role in antipsychotic drug actions. More information on the pharmacogenetics of CCL2 may therefore be useful in developing individualized therapy. However, to our knowledge, rare studies have been reported in this area. This investigation was attempted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemokine CCL2

Share to Pharmacogenetics

Share to Psychiatric Status Rating Scales

Share to Risperidone

Share to Schizophrenia

Share to Treatment Outcome

Source

Identifiers

PMID: 24495780
DOI: 10.1016/j.pnpbp.2014.01.017

Genes

CCL2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A pharmacogenetic study of risperidone on chemokine (C-C motif) ligand 2 (CCL2) in Chinese Han schizophrenia patients.PMID 24495780Read ↗

Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients.Semantic proximity Read ↗

Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.Semantic proximity Read ↗

HTR2C promoter polymorphisms are associated with risperidone efficacy in Chinese female patients.Semantic proximity Read ↗

Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study.Semantic proximity Read ↗

Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population.Semantic proximity Read ↗

Pharmacogenomic and inflammatory determinants of antipsychotic-induced extrapyramidal toxicity in Egyptian patients with schizophrenia.Semantic proximity Read ↗

COMT and Neuregulin 1 Markers for Personalized Treatment of Schizophrenia Spectrum Disorders Treated with Risperidone Monotherapy.Semantic proximity Read ↗

MCP-1 and CCR2 gene polymorphisms in Parkinson's disease in a Han Chinese cohort.Semantic proximity Read ↗

Expression of micro-RNAs miR-31, miR-146a, miR-181c and miR-155 and their target gene IL-2 are altered in schizophrenia: a case-control studySemantic proximity Read ↗

Association of CCL11 promoter polymorphisms with schizophrenia in a Korean population.Semantic proximity Read ↗

Association of dopamine receptor D1 (DRD1) polymorphisms with risperidone treatment response in Chinese schizophrenia patients.Semantic proximity Read ↗

The association between CCL2 polymorphisms and drug-resistant epilepsy in Chinese children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.